According to the research report titled ‘Global Clinical Nutrition Market 2019-2028‘, available with Market Study Report, global clinical nutrition market is expected to register 5.27% CAGR through 2028.
 

Rising incidence of chronic diseases such as diabetes & cancer, increasing number of malnutrition victims across the globe, and soaring geriatric population are catalyzing the growth of global clinical nutrition market. Additionally, rising product adoption in emerging countries is also augmenting the industry share.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552642/
 

Despite the positive outlook, risk of infectious complications which may arise from enteral feeding, false perceptions about malnutrition, and strict regulatory framework are likely to restrain the growth of the business domain over the analysis timeframe.
 

Speaking of application scope, worldwide clinical nutrition industry is classified into metabolic disorders, gastrointestinal disorders, neurological diseases, cancer, and others. Different routes of administration are parenteral, enteral, and oral. While various end-users include adults, geriatrics, and pediatrics.
 

As per regional analysis, North America is expected to hold a significant industry share by the end of forecast period, owing to adoption of preventive medical nutrition by different clinics & hospitals for treating chronic illnesses such as ischemic stroke, coronary artery disease, and others. Constant research & development activities in healthcare & nutrition field, and large geriatric population base who are susceptible to medical conditions will further impel the regional share.
 

The competitive landscape of global clinical nutrition industry is defined by companies such as American Regent, Inc., Baxter International, Inc., Exela Pharma Sciences LLC, Grifols, S.A., B. Braun Group, Danone S.A, Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Avadel Pharmaceuticals plc, BASF SE, Nestlé Health Science S.A., Reckitt Benckiser Group plc, Sichuan Kelun Pharmaceutical Co., Ltd., Lonza Group, Meiji Holdings Company Ltd., and Sanofi S.A. among others.